Q2 Oral Care Kit with CHG

Manufacturer
Halyard Health | Avent | Elba | Hi Tech Pharmacal
Effective date
2016-01-27
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 20:21:53

Label at a glance#

ProductQ2 Oral Care Kit with CHG
Active ingredientHydrogen peroxide, Chlorhexidine Gluconate
Label structure22 sections

Indications and uses

Aids in the removal of phlegm, mucus, or other secretions in the temporary relief of discomfort due to occasional sore throat and sore mouth.

Dosage and administration

Topical dosage for adults and children 3 years of age and older is a rinse used no more than 4 times daily. For children under 3 years of age, there is no recommended dosage except under the advice and supervision of a dentist or doctor. Use only under health care practitioners supervision.

Storage and handling

Store at room temperature.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Oral Debriding Agent

Drug Facts

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Hydrogen Peroxide 1.5%

Purpose

OTC - PURPOSE SECTION

Oral Debriding Agent

Uses

INDICATIONS & USAGE SECTION

  • Aids in the removal of phlegm, mucus, or other secretions in the temporary relief of discomfort due to occasional sore throat and sore mouth.

Warnings

WARNINGS SECTION

OTC - STOP USE SECTION

Stop use and ask a doctor if:

  • Swelling, rash, or fever develop.
  • Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea, and vomiting occurs.

OTC - DO NOT USE SECTION

  • Do not use more than 2 days or administer to children under 3 years of age unless directed by a physician.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children under 3 years of age.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Topical dosage for adults and children 3 years of age and older is a rinse used no more than 4 times daily. For children under 3 years of age, there is no recommended dosage except under the advice and supervision of a dentist or doctor.
  • Use only under health care practitioners supervision.

Other Information

STORAGE AND HANDLING SECTION

  • Store at room temperature.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Purified Water, Glycerin, Flavor, Sodium Saccharin

Questions or Comments?

OTC - QUESTIONS SECTION

1-844-425-9273

 

SPL UNCLASSIFIED SECTION

CHLORHEXIDINE GLUCONATE ORAL RINSE, 0.12%

Rx Only

DESCRIPTION

DESCRIPTION SECTION

Chlorhexidine Gluconate Oral Rinse, 0.12% is an oral rinse containing 0.12% chlorhexidine gluconate (1, 1'-hexamethylene bis[5-(p-chlorophenyl) biguanide] di-D-gluconate) in a base containing 11.6% v/v alcohol, FD&C Blue No. 1, glycerin, PEG-40 sorbitan diisostearate, peppermint flavor, sodium saccharin, and purified water. Chlorhexidine Gluconate Oral Rinse is a near-neutral solution (pH range 5-7). Chlorhexidine gluconate is a salt of chlorhexidine and gluconic acid. Its structural formula is: C22H30Cl2N10•2C6H12O7 MW = 897.8

Chemical Structure
Chemical Structure

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Chlorhexidine Gluconate Oral Rinse, 0.12% provides antimicrobial activity during oral rinsing. The clinical significance of 0.12% chlorhexidine gluconate oral rinse's anti-microbial activities is not clear. Microbiological sampling of plaque has shown a general reduction of counts of certain assayed bacteria, both aerobic and anaerobic, ranging from 54-97% through six months use. Use of chlorhexidine gluconate oral rinse in a six month clinical study did not result in any significant changes in bacterial resistance, overgrowth of potentially opportunistic organisms or other adverse changes in the oral microbial ecosystem. Three months after chlorhexidine gluconate use was discontinued, the number of bacteria in plaque had returned to baseline levels and resistance of plaque bacteria to chlorhexidine gluconate was equal to that at baseline.

PHARMACOKINETICS

PHARMACOKINETICS SECTION

Pharmacokinetic studies with a 0.12% chlorhexidine gluconate oral rinse indicate approximately 30% of the active ingredient, chlorhexidine gluconate, is retained in the oral cavity following rinsing. This retained drug is slowly released into the oral fluids. Studies conducted on human subjects and animals demonstrate chlorhexidine gluconate is poorly absorbed from the gastrointestinal tract. The mean plasma level of chlorhexidine gluconate reached a peak of 0.206 µg/g in humans 30 minutes after they ingested a 300-mg dose of the drug. Detectable levels of chlorhexidine gluconate were not present in the plasma of these subjects 12 hours after the compound was administered. Excretion of chlorhexidine gluconate occurred primarily through the feces (~90%). Less than 1% of the chlorhexidine gluconate ingested by these subjects was excreted in the urine.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

16 oz. Chlorhexidine Gluconate Oral Rinse, 0.12% - Chlorhexidine Gluconate Oral Rinse, 0.12% is indicated for use between dental visits as part of a professional program for the treatment of gingivitis as characterized by redness and swelling of the gingivae, including gingival bleeding upon probing. Chlorhexidine Gluconate Oral Rinse, 0.12% has not been tested among patients with acute necrotizing ulcerative gingivitis (ANUG). For patients having coexisting gingivitis and periodontitis, see PRECAUTIONS.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Chlorhexidine Gluconate Oral Rinse, 0.12% should not be used by persons who are known to be hypersensitive to chlorhexidine gluconate or other formula ingredients.

WARNINGS

WARNINGS SECTION

The effect of Chlorhexidine Gluconate Oral Rinse, 0.12% on periodontitis has not been determined. An increase in supragingival calculus was noted in clinical testing in users of chlorhexidine gluconate oral rinse compared with control users. It is not known if chlorhexicine gluconate use results in an increase in subgingival calculus. Calculus deposits should be removed by a dental prophylaxis at intervals not greater than six months. Hypersensitivity and generalized allergic reactions have occurred. See CONTRAINDICATIONS.

PRECAUTIONS

PRECAUTIONS SECTION

General

GENERAL PRECAUTIONS SECTION

  1. For patients having coexisting gingivitis and periodontitis, the presence or absence of gingival inflammation following treatment with Chlorhexidine Gluconate Oral Rinse, 0.12% should not be used as a major indicator of underlying periodontitis.
  2. Chlorhexidine Gluconate Oral Rinse, 0.12% can cause staining of oral surfaces, such as tooth surfaces, restorations, and the dorsum of the tongue. Not all patients will experience a visually significant increase in toothstaining. In clinical testing, 56% of chlorhexidine gluconate oral rinse users exhibited a measurable increase in facial anterior stain, compared to 35% of control users after six months; 15% of chlorhexidine gluconate users developed what was judged to be heavy stain, compared to 1% of control users after six months. Stain will be more pronounced in patients who have heavier accumulations of unremoved plaque. Stain resulting from use of Chlorhexidine Gluconate Oral Rinse, 0.12% does not adversely affect health of the gingivae or other oral tissues. Stain can be removed from most tooth surfaces by conventional professional prophylactic techniques. Additional time may be required to complete the prophylaxis. Discretion should be used when prescribing to patients with anterior facial restorations with rough surfaces or margins. If natural stain cannot be removed from these surfaces by a dental prophylaxis, patients should be excluded from Chlorhexidine Gluconate Oral Rinse, 0.12% treatment if permanent discoloration is unacceptable. Stain in these areas may be difficult to remove by dental prophylaxis and on rare occasions may necessitate replacement of these restorations.
  3. Some patients may experience an alteration in taste perception while undergoing treatment with chlorhexidine gluconate oral rinse. Rare instances of permanent taste alteration following chlorhexidine gluconate oral rinse have been reported via post-marketing product surveillance.

Pregnancy

PREGNANCY SECTION

Teratogenic Effects

TERATOGENIC EFFECTS SECTION

Pregnancy Category B

SPL UNCLASSIFIED SECTION

Reproduction studies have been performed in rats and rabbits at chlorhexidine gluconate doses up to 300 mg/kg/day and 40 mg/kg/day, respectively, and have not revealed evidence of harm to fetus. However, adequate and well-controlled studies in pregnant women have not been done. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

Nursing Mothers

NURSING MOTHERS SECTION

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Chlorhexidine Gluconate Oral Rinse, 0.12% is administered to nursing women.

In parturition and lactation studies with rats, no evidence of impaired parturition or of toxic effects to suckling pups was observed when chlorhexidine gluconate was administered to dams at doses that were over 100 times greater than that which would result from a person's ingesting 30 ml (2 capfuls) of chlorhexidine gluconate oral rinse, 0.12% per day.

Pediatric Use

PEDIATRIC USE SECTION

Clinical effectiveness and safety of Chlorhexidine Gluconate Oral Rinse, 0.12% have not been established in children under the age of 18

Carcinogenesis, Mutagenesis, and Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

In a drinking water study in rats, carcinogenic effects were not observed at doses up to 38 mg/kg/day. Mutagenic effects were not observed in two mammalian in vivo mutagenesis studies with chlorhexidine gluconate. The highest doses of chlorhexidine used in a mouse dominant-lethal assay and a hamster cytogenetics test were 1000 mg/kg/day and 250 mg/kg/day, respectively. No evidence of impaired fertility was observed in rats at doses up to 100 mg/kg/day.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

The most common side effects associated with chlorhexidine gluconate oral rinses are: 1) an increase in staining of teeth and other oral surfaces; 2) an increase in calculus formation; and 3) an alteration in taste perception, see WARNINGS and PRECAUTIONS. Oral irritation and local allergy-type symptoms have been spontaneously reported as side effects associated with use of chlorhexidine gluconate rinse.

The following oral mucosal side effects were reported during placebo-controlled adult clinical trials: aphthous ulcer, grossly obvious gingivitis, trauma, ulceration, erythema, desquamation, coated tongue, keratinization, geographic tongue, mucocele, and short frenum. Each occurred at a frequency of less than 1.0%. Among post marketing reports, the most frequently reported oral mucosal symptoms associated with chlorhexidine gluconate oral rinse, 0.12% are stomatitis, gingivitis, glossitis, ulcer, dry mouth, hypesthesia, glossal edema, and paresthesia.

Minor irritation and superficial desquamation of the oral mucosa have been noted in patients using chlorhexidine gluconate oral rinse, 0.12%.

There have been cases of parotid gland swelling and inflammation of the salivary glands (sialadentis) reported in patients using chlorhexidine gluconate oral rinse.

To report SUSPECTED ADVERSE REACTIONS, contact Hi-Tech Pharmacal Co., Inc. at 1-800-262-9010 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

OVERDOSAGE

OVERDOSAGE SECTION

Ingestion of 1 or 2 ounces of Chlorhexidine Gluconate Oral Rinse, 0.12% by a small child (~10 kg body weight) might result in gastric distress, including nausea, or signs of alcohol intoxication. Medical attention should be sought if more than 4 ounces of Chlorhexidine Gluconate Oral Rinse, 0.12% is ingested by a small child or if signs of alcohol intoxication develop.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Chlorhexidine Gluconate Oral Rinse, 0.12% therapy should be initiated directly following a dental prophylaxis. Patients using Chlorhexidine Gluconate Oral Rinse, 0.12% should be reevaluated and given a thorough prophylaxis at intervals no longer than six months.

Recommended use is twice daily oral rinsing for 30 seconds, morning and evening after toothbrushing. Usual dosage is 1/2 fl oz (marked in cup) of undiluted Chlorhexidine Gluconate Oral Rinse, 0.12%. Patients should be instructed to not rinse with water or other mouthwashes, brush teeth or eat immediately after using Chlorhexidine Gluconate Oral Rinse, 0.12%. Chlorhexidine Gluconate Oral Rinse, 0.12% is not intended for ingestion and should be expectorated after rinsing.

HOW SUPPLIED

HOW SUPPLIED SECTION

Chlorhexidine Gluconate Oral Rinse, 0.12% is a blue, peppermint flavored liquid in:

A 16 fl oz (473 mL) amber plastic bottle with a child-resistant closure and dosage cup for consumer use, and in 15 mL unit dose cups.

It should be dispensed in original container or in amber glass.

STORAGE AND HANDLING SECTION

Store above freezing 0°C (32°F).

SPL UNCLASSIFIED SECTION

Rx only

Manufactured by:
Hi-Tech
Pharmacal Co., Inc.
Amityville, NY 11701

Rev. 720:00 7/10
MG# 11387

PRINCIPAL DISPLAY PANEL - Kit Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

HALYARD*

24-HOUR
ORAL CARE KIT
with BALLARD* Technology

Use
with
CHG
▼
CHG

with
H2O2

q2

1
HALYARD*
Prep
Pack

2
HALYARD*
Toothbrush
Packs

4
HALYARD*
Suction Swab
Packs with H2O2

6
HALYARD*
Suction Swab Packs
with Alcohol-Free Mouthwash

2
HALYARD*
Suction Catheter
Packs

PRINCIPAL DISPLAY PANEL - Kit Carton
PRINCIPAL DISPLAY PANEL - Kit Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
834127chlorhexidine gluconate 0.12 % Oral RinsePSN1
834127chlorhexidine gluconate 1.2 MG/ML MouthwashSCD1
834127chlorhexidine gluconate 0.12 % MouthwashSY1
834127chlorhexidine gluconate 0.12 % Oral RinseSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CHLORHEXIDINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
9e37788c-b1bf-42ae-aac9-b60601606144Product name820260122
1527ac37-808d-43be-a63e-74e1258dbe46Product name920250219
bed0530e-f939-4541-956b-6928a2f6404fProduct name120241008
cefa60e2-a5b5-493e-9c54-24735b7dc509Product name620240814
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
6c13b22c-b3ba-4127-b768-0132dd5ab0d1Product name120230829
9fcb7a91-de07-4f00-aabf-e4d6fda403d5Product name820230322
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
c6f86816-7da6-43ea-8c25-ac9758311cc5Product name120220118
9badc7be-250a-44ab-aa36-926af3f02679Product name120210527
0ec3537a-6c9b-432a-896c-b9ea8723049aProduct name920200701
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
7916de40-e296-41f0-b811-6d0df1a33e2cProduct name920180627
cefa60e2-a5b5-493e-9c54-24735b7dc509Product name220171212
252e11b6-1a9a-4283-a242-df2c129c496dProduct name320170717
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
bb6d6c68-649d-4e6d-a1f6-603d969c8f68Product name120160303
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69697-982-012020-01-31C16284748780-19d75b9cf-fcbf-f424-e053-dadaa90a57ceHalyard 24-Hour Oral Care Kit Q2

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50383-720-15Q2 Oral Care Kit with CHG15 mL in 1 CUP, UNIT-DOSERINSE150 mL1.2 mg in 1mL1
50383-720-15Q2 Oral Care Kit with CHG10 in 1 TRAYRINSE1.2 mg in 1mL1
69697-982-01Q2 Oral Care Kit with CHG1 in 1 CARTONKIT11
69697-991-01Q2 Oral Care Kit with CHG14 mL in 1 CUP, UNIT-DOSEMOUTHWASH56 mL0.015 mg in 1mL1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50383-720Q2 ORAL CARE KIT WITH CHG (HYDROGEN PEROXIDE AND CHLORHEXIDINE GLUCONATE) KIT [HALYARD HEALTH]1Legacy NDC20160128_b2f446b9-9f9f-4380-b5dc-55e3a1c06fff.zip
69697-982Q2 ORAL CARE KIT WITH CHG (HYDROGEN PEROXIDE AND CHLORHEXIDINE GLUCONATE) KIT [HALYARD HEALTH]1Legacy NDC, 4 package rows20160128_b2f446b9-9f9f-4380-b5dc-55e3a1c06fff.zip
69697-991Q2 ORAL CARE KIT WITH CHG (HYDROGEN PEROXIDE AND CHLORHEXIDINE GLUCONATE) KIT [HALYARD HEALTH]1Unmatched20160128_b2f446b9-9f9f-4380-b5dc-55e3a1c06fff.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50383-720-15ML - Milliliter50383-720ed7935df-0806-436b-89a7-494cd0c540d712012-07-24
50383-720-16ML - Milliliter50383-720ffeac45b-1bfc-4e4e-abca-55bd5f2035cf12012-07-24
50383-720-17ML - Milliliter50383-72031dbe587-c3bf-4013-9056-f852d054fe3912013-05-02
50383-720-19ML - Milliliter50383-7202e49c64a-1a7a-442a-91ff-5e9d18b8b3d912013-05-02

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 27 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69697-98269697-982-01
69697-99169697-991-01
50383-72050383-720-15

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 32 matching rows.

Source Document#

Source XML · Source PDF

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A074356-001CHLORHEXIDINE GLUCONATECHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-07

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-07c2088c7a36db…
2026-09-14 22:38:342026-08A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-0784e616aacf4f…
2026-08-18 06:07:402026-07A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-07caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-07011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-0731067a03dcf5…
2025-08-23 18:47 UTC2025-08A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-076a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-07fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-07b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-0703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-072680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-075bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-07d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-07d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-0779d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-07301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-071e350fbaab3a…
2024-05-31 18:47 UTC2024-05A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-078072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT1996-05-075c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT1996-05-075d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT1996-05-074b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT1996-05-0774a2ff9319b5…
2022-03-09 01:35 UTC2022-03A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT1996-05-07bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT1996-05-07782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT1996-05-0787673890dc5c…
2021-03-12 10:30 UTC2021-03A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT1996-05-075aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT1996-05-078869cabd3fbd…
2020-11-12 02:37 UTC2020-11A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT1996-05-07c0c555d07b60…
2019-12-14 00:12 UTC2019-12A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT1996-05-073f01610625f2…
2019-09-15 20:21 UTC2019-09A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT1996-05-07b00525d2431f…
2019-07-19 19:46 UTC2019-07A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT1996-05-07ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-076a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-071c564ffb4f44…
2023-12-20 04:57 UTC2023-12A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-07ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-07a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-079b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-07a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-073f0d92c62455…
2023-05-13 08:27 UTC2023-05A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-07053a50430f4f…
2023-01-26 05:58 UTC2023-01A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-073bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A074356-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTAL1996-05-073a93d1ddd44b…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A074356-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A074356-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A074356-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A074356-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A074356-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A074356-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A074356-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A074356-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A074356-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A074356-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A074356-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A074356-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A074356-001AT1ea99ee380514…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A074356-001AT1cb3db0bc1861…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
35c8ebed-889e-4732-bd81-af8999553bf5b2f446b9-9f9f-4380-b5dc-55e3a1c06fff2016-01-27Warnings, Adverse reactionsExact identifier
spl id: 35c8ebed-889e-4732-bd81-af8999553bf5
spl set id: b2f446b9-9f9f-4380-b5dc-55e3a1c06fff

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.